Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06152224 · ClinicalTrials.gov registry record · Phase 4
Use of the LEVA® Pelvic Health System for Fecal Incontinence
A Phase 4 study of Fecal Incontinence, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT06152224 is a Phase 4 study of Fecal Incontinence that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 38 participants, below the 333-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06152224, a Phase 4 study of Fecal Incontinence, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about how the duration of use of The Leva Pelvic Health System® affects treatment of fecal incontinence in women. The main question it aims to answer is to test whether use of the The Leva Pelvic Health System® for 8 weeks is as good as using it for 16 weeks. Participants will complete surveys, and use the Leva device.
Conditions Studied
Interventions
- DEVICE The Leva Pelvic Health System
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2024-01-17 |
| Est. Completion | 2026-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06152224
The ClinicalTrials.gov registry entry for NCT06152224 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 333-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (89% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fecal Incontinence appearing as the primary indexed condition, and to 1 intervention - of which The Leva Pelvic Health System is the first listed.
NCT06152224 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06152224 about?
NCT06152224 is a clinical study titled "Use of the LEVA® Pelvic Health System for Fecal Incontinence". The goal of this clinical trial is to learn about how the duration of use of The Leva Pelvic Health System® affects treatment of fecal incontinence in women. The main question it aims to answer is to test whether use of the The Leva Pelvic Health System® for 8 weeks is as good as using it for 16 wee...
What is the current status of trial NCT06152224?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2024-01-17. Estimated completion is 2026-09.
What conditions does trial NCT06152224 study?
This clinical trial studies the following conditions: Fecal Incontinence.
What interventions are being tested in trial NCT06152224?
The interventions under investigation include: The Leva Pelvic Health System (DEVICE).
Who is sponsoring clinical trial NCT06152224?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06152224 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fecal Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Mechanisms of Improving Fecal Continence Muscles Motor Function
RECRUITING · NA
-
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
RECRUITING · NA
-
Autologous Muscle Fiber Fragment Injections
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.